Cellosaurus CAL-39 (CVCL_1109)

Cell line name CAL-39
Synonyms CAL 39; CAL39
Accession CVCL_1109
Resource Identification Initiative To cite this cell line use: CAL-39 (RRID:CVCL_1109)
Comments Doubling time: 30 hours, at 34th passage (PubMed=21573363); ~50-70 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Disease Vulvar squamous cell carcinoma (NCIt: C4052)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DSMZ

Markers:
AmelogeninX
CSF1PO12
D13S31712,13
D16S5399,11
D5S81812
D7S8208
TH016,7
TPOX8
vWA16,17
Publications

PubMed=21573363; DOI=10.3892/ijo.3.2.293
Gioanni J., Grosgeorge J., Zanghellini E., Mazeau C., Gaudray P., Ettore F., Formento P., Demard F.
Characterization of CAL39, a new human cell-line derived from a vulvar squamous-cell carcinoma.
Int. J. Oncol. 3:293-297(1993)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections DSMZ; ACC-187
Cell line databases/resources CLDB; cl630
Cosmic-CLP; 924107
GDSC; 924107
LINCS_LDP; LCL-1294
Ontologies CLO; CLO_0002184
Biological sample resources BioSample; SAMN03473368
Chemistry resources ChEMBL-Cells; CHEMBL3308716
ChEMBL-Targets; CHEMBL1075410
Gene expression databases GEO; GSM1669651
Polymorphism and mutation databases Cosmic; 924107
Cosmic; 1995358